474 related articles for article (PubMed ID: 16272861)
1. Three-phase dynamic breast magnetic resonance imaging with two-way subtraction.
Choi N; Han BK; Choe YH; Kim HS
J Comput Assist Tomogr; 2005; 29(6):834-41. PubMed ID: 16272861
[TBL] [Abstract][Full Text] [Related]
2. Breast lesions: evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging.
Kvistad KA; Rydland J; Vainio J; Smethurst HB; Lundgren S; Fjøsne HE; Haraldseth O
Radiology; 2000 Aug; 216(2):545-53. PubMed ID: 10924584
[TBL] [Abstract][Full Text] [Related]
3. MR features to suggest microinvasive ductal carcinoma of the breast: can it be differentiated from pure DCIS?
Hahn SY; Han BK; Ko EY; Shin JH; Hwang JY; Nam M
Acta Radiol; 2013 Sep; 54(7):742-8. PubMed ID: 23588154
[TBL] [Abstract][Full Text] [Related]
4. Relationship between lesion size and signal enhancement on subtraction fat-suppressed MR imaging of the breast.
Cheung HS; Tse GM; Lai SY; Yeung DK
Magn Reson Imaging; 2004 Nov; 22(9):1259-64. PubMed ID: 15607097
[TBL] [Abstract][Full Text] [Related]
5. MR dynamic enhancement of breast lesions: high temporal resolution during the first-minute versus eight-minute study.
Sardanelli F; Rescinito G; Giordano GD; Calabrese M; Parodi RC
J Comput Assist Tomogr; 2000; 24(5):724-31. PubMed ID: 11045693
[TBL] [Abstract][Full Text] [Related]
6. Combination of low and high resolution sequences in two orientations for dynamic contrast-enhanced MRI of the breast: more than a compromise.
Vomweg TW; Teifke A; Kunz RP; Hintze C; Hlawatsch A; Kern A; Kreitner KF; Thelen M
Eur Radiol; 2004 Oct; 14(10):1732-42. PubMed ID: 15378253
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the three-time-point method for diagnosis of breast lesions in contrast-enhanced MR mammography.
Hauth EA; Stockamp C; Maderwald S; Mühler A; Kimmig R; Jaeger H; Barkhausen J; Forsting M
Clin Imaging; 2006; 30(3):160-5. PubMed ID: 16632149
[TBL] [Abstract][Full Text] [Related]
8. Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features.
Stomper PC; Herman S; Klippenstein DL; Winston JS; Edge SB; Arredondo MA; Mazurchuk RV; Blumenson LE
Radiology; 1995 Nov; 197(2):387-95. PubMed ID: 7480682
[TBL] [Abstract][Full Text] [Related]
9. Morphologic blooming in breast MRI as a characterization of margin for discriminating benign from malignant lesions.
Penn A; Thompson S; Brem R; Lehman C; Weatherall P; Schnall M; Newstead G; Conant E; Ascher S; Morris E; Pisano E
Acad Radiol; 2006 Nov; 13(11):1344-54. PubMed ID: 17070452
[TBL] [Abstract][Full Text] [Related]
10. Dynamic contrast-enhanced magnetic resonance imaging of the breast combined with pharmacokinetic analysis of gadolinium-DTPA uptake in the diagnosis of local recurrence of early stage breast carcinoma.
Mussurakis S; Buckley DL; Bowsley SJ; Carleton PJ; Fox JN; Turnbull LW; Horsman A
Invest Radiol; 1995 Nov; 30(11):650-62. PubMed ID: 8557506
[TBL] [Abstract][Full Text] [Related]
11. Breast DCE-MRI: influence of postcontrast timing on automated lesion kinetics assessments and discrimination of benign and malignant lesions.
Partridge SC; Stone KM; Strigel RM; DeMartini WB; Peacock S; Lehman CD
Acad Radiol; 2014 Sep; 21(9):1195-203. PubMed ID: 24998690
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic performance of ADC for Non-mass-like breast lesions on MR imaging.
Imamura T; Isomoto I; Sueyoshi E; Yano H; Uga T; Abe K; Hayashi T; Honda S; Yamaguchi T; Uetani M
Magn Reson Med Sci; 2010; 9(4):217-25. PubMed ID: 21187691
[TBL] [Abstract][Full Text] [Related]
13. Automatic identification and classification of characteristic kinetic curves of breast lesions on DCE-MRI.
Chen W; Giger ML; Bick U; Newstead GM
Med Phys; 2006 Aug; 33(8):2878-87. PubMed ID: 16964864
[TBL] [Abstract][Full Text] [Related]
14. Dynamic bilateral contrast-enhanced MR imaging of the breast: trade-off between spatial and temporal resolution.
Kuhl CK; Schild HH; Morakkabati N
Radiology; 2005 Sep; 236(3):789-800. PubMed ID: 16118161
[TBL] [Abstract][Full Text] [Related]
15. Clustered breast microcalcifications: evaluation by dynamic contrast-enhanced subtraction MRI.
Gilles R; Meunier M; Lucidarme O; Zafrani B; Guinebretière JM; Tardivon AA; Le Gal M; Vanel D; Neuenschwander S; Arriagada R
J Comput Assist Tomogr; 1996; 20(1):9-14. PubMed ID: 8576489
[TBL] [Abstract][Full Text] [Related]
16. Renal masses: quantitative analysis of enhancement with signal intensity measurements versus qualitative analysis of enhancement with image subtraction for diagnosing malignancy at MR imaging.
Hecht EM; Israel GM; Krinsky GA; Hahn WY; Kim DC; Belitskaya-Levy I; Lee VS
Radiology; 2004 Aug; 232(2):373-8. PubMed ID: 15215544
[TBL] [Abstract][Full Text] [Related]
17. Low-field versus high-field MRI in diagnosing breast disorders.
Pääkkö E; Reinikainen H; Lindholm EL; Rissanen T
Eur Radiol; 2005 Jul; 15(7):1361-8. PubMed ID: 15711841
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of breast tumors by contrast-enhanced MR imaging: comparison between the diagnostic performance of dynamic enhancement patterns and morphologic features.
Goto M; Ito H; Akazawa K; Kubota T; Kizu O; Yamada K; Nishimura T
J Magn Reson Imaging; 2007 Jan; 25(1):104-12. PubMed ID: 17152054
[TBL] [Abstract][Full Text] [Related]
19. Enhancing area surrounding breast carcinoma on MR mammography: comparison with pathological examination.
Van Goethem M; Schelfout K; Kersschot E; Colpaert C; Verslegers I; Biltjes I; Tjalma WA; Weyler J; De Schepper A
Eur Radiol; 2004 Aug; 14(8):1363-70. PubMed ID: 15045522
[TBL] [Abstract][Full Text] [Related]
20. In situ and minimally invasive breast cancer: morphologic and kinetic features on contrast-enhanced MR imaging.
Viehweg P; Lampe D; Buchmann J; Heywang-Köbrunner SH
MAGMA; 2000 Dec; 11(3):129-37. PubMed ID: 11154954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
